Literature DB >> 9270002

A p53-independent pathway for induction of p21waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts.

M Loignon1, R Fetni, A J Gordon, E A Drobetsky.   

Abstract

Largely on the basis of studies using the potent clastogen ionizing radiation, it has been widely assumed that up-regulation of the cyclin-dependent kinase inhibitor p21(waf1cip1) in cultured cells exposed to DNA-damaging agents is contingent upon the presence of functional p53 tumor suppressor protein. Nevertheless, we demonstrate here that the model mutagen 254-nm UV light induces p21(waf1cip1) protein and concomitant G1 arrest in normal human skin fibroblasts, as well as in p53-deficient fibroblasts derived from cancer-prone Li-Fraumeni syndrome patients. However, as expected, following exposure to ionizing radiation, elevated p21(waf1cip1) protein levels and G1 arrest were observed only in normal fibroblasts. These data provide a prominent and clinically relevant example in which p21(waf1cip1)-mediated growth arrest occurs independently of p53 in human cells treated with a model DNA-damaging agent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270002

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  Role for p53 in the recovery of transcription and protection against apoptosis induced by ultraviolet light.

Authors:  B C McKay; M Ljungman
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression.

Authors:  R Utrera; L Collavin; D Lazarević; D Delia; C Schneider
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

4.  p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells.

Authors:  D B Zamble; T Jacks; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells.

Authors:  Huda H Al-Khalaf; Boleslaw Lach; Ayman Allam; Ahmed AlKhani; Salman A Alrokayan; Abdelilah Aboussekhra
Journal:  J Neurooncol       Date:  2007-01-24       Impact factor: 4.130

6.  The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12.

Authors:  Eva Roubalová; Veronika Kvardová; Roman Hrstka; Sárka Borilová; Eva Michalová; Lenka Dubská; Petr Müller; Petr Sova; Borivoj Vojtesek
Journal:  Invest New Drugs       Date:  2009-06-05       Impact factor: 3.850

7.  Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells.

Authors:  Stéphane Ouellet; François Vigneault; Maryse Lessard; Steeve Leclerc; Régen Drouin; Sylvain L Guérin
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

8.  The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light.

Authors:  Mai A Al-Mohanna; Huda H Al-Khalaf; Nujoud Al-Yousef; Abdelilah Aboussekhra
Journal:  Nucleic Acids Res       Date:  2006-12-07       Impact factor: 16.971

9.  Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.

Authors:  J F Mirjolet; M Barberi-Heyob; C Didelot; J P Peyrat; J Abecassis; R Millon; J L Merlin
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

10.  UVB Inhibits Proliferation, Cell Cycle and Induces Apoptosis via p53, E2F1 and Microtubules System in Cervical Cancer Cell Lines.

Authors:  Angelica Judith Granados-López; Eduardo Manzanares-Acuña; Yamilé López-Hernández; Julio Enrique Castañeda-Delgado; Ixamail Fraire-Soto; Claudia Araceli Reyes-Estrada; Rosalinda Gutiérrez-Hernández; Jesús Adrián López
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.